Johnson & Johnson presented new data on its investigational treatment, nipocalimab, at the 2025 American Academy of Neurology ...

On a day that held a special meaning for one woman, a simple DoorDash delivery turned into an unforgettable reunion ...

Accelerating clinical path to commercialization in stiff person syndrome, myasthenia gravis and lupus nephritis Aligned with the U.S. Food and Drug Administration (FDA) ...

Corient Private Wealth LLC grew its holdings in shares of argenx SE (NASDAQ:ARGX – Free Report) by 14.7% in the 4th quarter, ...

以往研究发现，MuSK-ab 阳性的 MG 患者使用 Pyridostigmine 时，更容易出现心脏传导方面的问题，像持续性窦性心动过缓、高度窦房阻滞等。但 MuSK-ab 阴性的患者情况如何呢？这成了一个悬而未决的问题。为了弄清楚这个疑问，来自 Babol 大学医学科学（Babol University of Medical Science）的 Mohammad Taghi Hedayati ...

“It’s been a real roller coaster these past months,” shares the actress through an Instagram post. “I was diagnosed with an ...

Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts ...

Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts ...

Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and neurological diseases; Initial data for NKX ...

Colt Ford is lucky to be alive after suffering a heart attack after a show in Arizona in April of 2024. The country singer ...

Dr Nicholas Silvestri looks ahead to new data on existing agents and emerging therapies for myasthenia gravis.

Rozanolixizumab is a high-affinity humanized immunoglobulin G4 monoclonal antibody and Fc receptor blocker approved to treat ...